1 documents found
Information × Registration Number 0120U104476, R & D request Title A 52-week randomized, double-blind, placebo-controlled phase 3 study to evaluate the safety and efficacy of relamorelin in patients with diabetic gastroparesis Head Katerenchuk Vitalii I., Registration Date 21-10-2020 Organization Ukrainian medical stomatological Academy popup.description1 study to evaluate the safety and efficacy of relamorelin in patients with diabetic gastroparesis popup.nrat_date 2024-12-10 Close
search.res_rk
A 52-week randomized, double-blind, placebo-controlled phase 3 study to evaluate the safety and efficacy of relamorelin in patients with diabetic gastroparesis
Head: Katerenchuk Vitalii I.. A 52-week randomized, double-blind, placebo-controlled phase 3 study to evaluate the safety and efficacy of relamorelin in patients with diabetic gastroparesis. Ukrainian medical stomatological Academy. № 0120U104476
1 documents found

Updated: 2026-03-23


Роздрукувати цю сторінку